Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus

Go back to Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus
(NASDAQ: APYX) Delayed: 4.69 +0.04 (0.86%)
Previous Close $4.65    52 Week High
Open $4.66    52 Week Low
Day High $4.99    P/E N/A 
Day Low $4.63    EPS
Volume 119,603